Reliq Health Technologies, Inc. to Present at the Lytham Partners Spring 2022 Investor Conference
Reliq Health Technologies (OTC:RQHTF) announced its participation in the Lytham Partners Spring 2022 Investor Conference from April 4-7, 2022. CEO Dr. Lisa Crossley highlighted expectations for significant growth in 2022, supported by increased reimbursements from CMS for virtual care services through its iUGO Care platform. The company targets a patient population of over 60 million in the U.S., with recent quarterly gross margins reaching 74%. A webcast presentation will occur at 11:00 AM EDT on April 4, with a panel discussion on innovating patient care on April 5.
- None.
- None.
HAMILTON, Ontario, March 31, 2022 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, announced today that it will be participating in the Lytham Partners Spring 2022 Investor Conference taking place virtually on April 4 - 7, 2022.
“We’re very pleased to be participating in the Lytham Partners Spring 2022 Investor Conference next week,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “We expect 2022 to be a year of unprecedented growth for the Company, driven by the increased reimbursement from the Centers for Medicare and Medicaid Services (CMS) for the virtual care services our iUGO Care platform enables. In this quarter alone, Reliq has expanded our platform to address new verticals including musculoskeletal conditions, respiratory conditions, dentistry, enhanced care for complex mental health and addiction patients and clinical trials, and we have expanded geographically into Nevada. We now have a target patient population of over 60 Million patients in the US alone. The Company reported gross margins of
The Company’s webcast presentation will be available for viewing at 11:00am EDT on Monday, April 4, 2022, on the Company's website or at: https://wsw.com/webcast/lytham4/rht.v/2139702.
The Company will also participate in a healthcare industry panel titled “Improving Patient Care through New Innovations.” The panel, to be conducted virtually, will be held on Tuesday, April 5, 2022, at 11:00am EDT. To access the panel, please visit: https://wsw.com/webcast/lytham4/panel2/2265382.
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1x1@lythampartners.com or register at www.lythampartners.com/spring2022invreg.
Reliq Health
Reliq Health Technologies is a rapidly growing global healthcare technology company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the WKN as A2AJTB.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information please contact:
Company Contact
Investor Relations at ir@reliqhealth.com
US Investor Relations Contact
Investor Relations
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix
646-829-9701
shamsian@lythampartners.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
FAQ
What is Reliq Health Technologies' stock symbol?
When is the Lytham Partners Spring 2022 Investor Conference?
What are the expected gross margins for Reliq Health in 2022?
What is the iUGO Care platform by Reliq Health?
How many patients does Reliq Health target in the U.S.?
